(Q31038008)

28 June 2017

1 reference

title

Acetylcysteine treatment for non-acetaminophen-induced acute liver failure (English)

1 reference

28 June 2017

1 reference

1 reference

Grant E Sklar

1

1 reference

28 June 2017

Malar Subramaniam

series ordinal

2

1 reference

28 June 2017

language of work or name

English

0 references

publication date

12 January 2004

1 reference

Annals of Pharmacotherapy

28 June 2017

published in

1 reference

28 June 2017

volume

38

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

498-500

1 reference

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

28 June 2017

cites work

1 reference

Reducing paracetamol overdoses

21 January 2018

1 reference

Acetaminophen hepatotoxicity

21 January 2018

1 reference

Review article: the management of acute liver failure

21 January 2018

1 reference

Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine

21 January 2018

1 reference

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial

21 January 2018

1 reference

Early indicators of prognosis in fulminant hepatic failure

21 January 2018

1 reference

Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure

21 January 2018

1 reference

N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.

21 January 2018

1 reference

The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.

21 January 2018

1 reference

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D209

1 reference

28 June 2017

1 reference